Prana Provides Huntington Disease Trial Update in conjunction with the Huntington Study Group Annual Conference July 17, 2013
FDA Approval to Commence Huntington’s Disease Clinical Trial Using Prana’s PBT2: Huntington Study Group appointed to coordinate the trial and start recruitment July 17, 2013
